Cargando…
ATM mediates DAB2IP-deficient bladder cancer cell resistance to ionizing radiation through the p38MAPK and NF-κB signaling pathway
Although surgery remains the standard therapy for the treatment of bladder cancer (BCa), the data from previous clinical studies suggest that there is an increase in the number of patients with a preference for bladder preservation strategies, including radiotherapy, to improve their life quality. O...
Autores principales: | He, Hui, Chang, Rulve, Zhang, Tingting, Yang, Chen, Kong, Zhaolu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561968/ https://www.ncbi.nlm.nih.gov/pubmed/28586028 http://dx.doi.org/10.3892/mmr.2017.6689 |
Ejemplares similares
-
DAB2IP in cancer
por: Liu, Liang, et al.
Publicado: (2015) -
Low expression of DAB2IP predicts an unfavorable prognosis in human bladder carcinoma
por: Zheng, Linfeng, et al.
Publicado: (2017) -
Downregulation of DAB2IP results in cell proliferation and invasion and contributes to unfavorable outcomes in bladder cancer
por: Shen, Yi-Jun, et al.
Publicado: (2014) -
Aberrant promoter methylation in human DAB2 interactive protein (hDAB2IP) gene in gastrointestinal tumour
por: Dote, H, et al.
Publicado: (2005) -
Sourcebook of ATM and IP internetworking
por: Ahmad, Khalid
Publicado: (2001)